Statin induces apoptosis and cell growth arrest in prostate cancer cells

Cancer Epidemiology Biomarkers and Prevention

Volumn 17, Issue 1, 2008, Pages 88-94

  Hoque, Ashraful ^a   Chen, Hongli ^a   Xu, Xiao Chun ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 8; CYCLIN D1; CYCLIN D3; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; CYCLOOXYGENASE 2; DEOXYURIDINE TRIPHOSPHATE PYROPHOSPHATASE; DNA NUCLEOTIDYLEXOTRANSFERASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; PROTEIN C JUN; PROTEIN P21; PROTEIN P27; RETINOBLASTOMA PROTEIN; RHO KINASE; SIMVASTATIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL GROWTH; CELL STRAIN DU145; CELL STRAIN LNCAP; CELL STRAIN PC3; CELL VIABILITY; DNA FRAGMENTATION; DRUG MECHANISM; HUMAN; HUMAN CELL; MALE; NICK END LABELING; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; WESTERN BLOTTING;

APOPTOSIS; BLOTTING, WESTERN; CELL CYCLE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; IN SITU NICK-END LABELING; LOVASTATIN; MALE; PROSTATIC NEOPLASMS; SIMVASTATIN; TUMOR CELLS, CULTURED;

EID: 38849106752     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-07-0531     Document Type: Article

References (32)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007. CA Cancer J Clin 2007;57:43-66.
2. Oesterling JE, Fuks Z, Lee CL, Scher HI. Cancer of the prostate. In: DeVita VT, Jr., Hellman S, Rosenberg SA, editors. Cancer: Principles and Practice of Oncology. Lippincott-Raven Publishers, Philadelphia; 1997. p. 1322-86.
3. Klein EA. Chemoprevention of prostate cancer. Annu Rev Med 2006;5:49-63.
4. Demierre MF, Higgins PD, Gruber SB, Hawk E, Lippman SM. Statins and cancer prevention. Nat Rev Cancer 2005;5:930-42.
5. Shannon J, Tewoderos S, Garzotto M, et al. Statins and prostate cancer risk: a case-control study. Am J Epidemiol 2005;162:318-25.
6. Graaf MR, Beiderbeck AB, Egberts AC, et al. The risk of cancer in users of statins. J Clin Oncol 2004;22:2388-94.
7. Cyrus-David MS, Weinberg A, Thompson T, et al. The effect of statins on serum prostate specific antigen levels in a cohort of airline pilots: a preliminary report. J Urol 2005;173:1923-5.
8. Moyad MA. Why a statin and/or another proven heart healthy agent should be utilized in the next major cancer chemoprevention trial: part I. Urol Oncol 2004;22:466-71.
9. Moyad MA. Why a statin and/or another proven heart healthy agent should be utilized in the next major cancer chemoprevention trial: part II. Urol Oncol 2004;22:472-7.
10. Wong WW, Dimitroulakos J, Minden MD, et al. HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis. Leukemia 2002;16:508-19.
11. Wu J, Wong WW, Khosravi F et al. Blocking the Raf/MEK/ERK pathway sensitizes acute myelogenous leukemia cells to lovastatin-induced apoptosis. Cancer Res 2004;64:6461-8.
12. Cafforio P, Dammacco F, Gernone A, et al. Statins activate the mitochondrial pathway of apoptosis in human lymphoblasts and myeloma cells. Carcinogenesis 2005;26:883-91.
13. Werner M, Sacher J, Hohenegger M. Mutual amplification of apoptosis by statin-induced mitochondrial stress and doxorubicin toxicity in human rhabdomyosarcoma cells. Br J Pharmacol 2004;143:715-24.
14. Graaf MR, Richel DJ, van Noorden CJ, et al. Effects of statins and farnesyltransferase inhibitors on the development and progression of cancer. Cancer Treat Rev 2004;30:609-41.
15. Vincent L, Chen W, Hong L, et al. Inhibition of endothelial cell migration by cerivastatin, an HMG-CoA reductase inhibitor: contribution to its anti-angiogenic effect. FEBS Lett 2001;495:159-66.
16. Subbarayan V, Xu X-C, Kim J, et al Inverse relationship between 15-lipoxygenase-2 and peroxisome proliferator-activated receptor-γ gene expression in normal epithelia compared with tumor epithelia. Neoplasia 2005;7:280-93.
17. Hoque A, Lippman SM, Wu TT, et al. Increased 5-lipoxygenase expression and induction of apoptosis by its inhibitors in esophageal cancer: a potential target for prevention. Carcinogenesis 2005;26:785-91.
18. Liang ZD, Lippman SM, Wu TT, et al. RRIG1 mediates effects of retinoic acid receptor-β2 on tumor cell growth and gene expression through binding to and inhibiting RhoA. Cancer Res 2006;66:7111-8.
19. Marinissen MJ, Chiariello M, Tanos T, et al. The small GTP-binding protein RhoA regulates c-jun by a ROCK-JNK signaling axis. Mol Cell 2004;14:29-41.
20. Goldstraw MA, Amoroso P, Kirby RS. Do statins protect against prostate cancer? BJU Int 2006;97:1147-8.
21. Li M, Wu X, Xu X-C. Induction of Apoptosis in colon cancer cells by cyclooxygenase-2 inhibitor NS398 through a cytochrome c-dependent pathway. Clin Cancer Res 2001;7:1010-6.
22. Li M, Wu X, Xu X-C. Induction of apoptosis by cyclooxygenase-2 inhibitor NS398 through a cytochrome c-dependent pathway in esophageal cancer cells. Int J Cancer 2001;93:218-23.
23. Israels LG, Israels ED. Apoptosis. Oncologist 1999;4:332-9.
24. Dale KM, Coleman CI, Henyan NN, et al. Statins and cancer risk: a meta-analysis. JAMA 2006;295:74-80.
25. Duncan RE, El-Sohemy A, Archer MC. Statins and the risk of cancer. JAMA 2006;295:2720; author reply 2721-2.
26. Freeman MR, Solomon KR, Moyad M. Statins and the risk of cancer. JAMA 2006;295:2720-1;author reply 2721-2.
27. Salinas CA, Agalliu I, Stanford JL, Lin DW. Statins and the risk of cancer. JAMA 2006;295:2721;author reply 2721-2.
28. Lee SJ, Ha MJ, Lee J, et al. Inhibition of the 3-hydroxy-3- methylglutaryl-coenzyme A reductase pathway induces p53-independent transcriptional regulation of p21(WAF1/CIP1) in human prostate carcinoma cells. J Biol Chem 1998;273:10618-23.
29. Lee J, Lee I, Park C, et al. Lovastatin-induced RhoA modulation and its effect on senescence in prostate cancer cells. Biochem Biophys Res Commun 2006;339:748-54.
30. Efuet ET, Keyomarsi K. Farnesyl and geranylgeranyl transferase inhibitors induce G1 arrest by targeting the proteasome. Cancer Res 2006;66:1040-51.
31. Chen JC, Huang KC, Wingerd B, et al. HMG-CoA reductase inhibitors induce COX-2 gene expression in murine macrophages: role of MAPK cascades and promoter elements for CREB and C/EBPβ. Exp Cell Res 2004;301:305-19.
32. Degraeve F, Bolla M, Blaie S, et al. Modulation of COX-2 expression by statins in human aortic smooth muscle cells. Involvement of geranylgeranylated proteins. J Biol Chem 2001;276:46849-55.